Loading the page…
Nasdaq 100
ISRG
Intuitive Surgical, Inc., Health Care
$432.01
−3.73% on the day
Close of Fri, Oct 30, 2026
+22.3% over 3M
2026-07-312026-09-162026-10-30
Market cap$149.8B
Last close$432.01
Day move−3.73%
Nasdaq 100
Intuitive Surgical, Inc., Health Care
$432.01
−3.73% on the day
Close of Fri, Oct 30, 2026
| Quarter ending | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025* | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024* |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.9B | $2.8B | $2.9B | $2.5B | $2.4B | $2.3B | $2.4B |
| Gross margin | 68.4% | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% | 64.7% | 68.0% |
| Operating margin | 19.4% | 33.6% | 30.9% | 30.2% | 30.3% | 30.5% | 25.7% | 30.4% |
| Net margin | 17.1% | 28.3% | 29.6% | 27.7% | 28.1% | 27.0% | 31.0% | 28.4% |
| EPS, diluted | $1.49 | $2.29 | $2.28 | $2.19 | $1.95 | $1.81 | $1.92 | $1.89 |
From the company's SEC filings, newest first. * A fiscal fourth quarter: the year's 10-K less its first three quarters.
The same ranks the builder's sliders blend. Small and Wild are Big and Calm turned over.
| Measure | ISRG | Higher than |
|---|---|---|
| Earnings yield (earnings ÷ price) | 2.0% | 29% |
| Book yield (book value ÷ price) | 10.7% | 52% |
| Free cash flow yield | 2.0% | 37% |
| Buyback yield | 1.5% | 67% |
| Revenue growth, a year | 20.5% | 71% |
| EPS growth, a year | 22.6% | 59% |
| Return on equity | 18.5% | 43% |
| Return on assets | 15.3% | 66% |
| Net margin | 25.5% |
Research
Figures from SEC filings and daily closes; results dates and headlines from Yahoo Finance and Nasdaq; insider trades from SEC Form 4. For learning, not investment advice.
| 71% |
| Liabilities ÷ assets | 16.7% | 6% |
|---|
| Past year, skipping last month | -25.4% | 15% |
|---|
| Past 6 months, skipping last month | -12.4% | 22% |
|---|
| Volatility, a year's worth | 29.8% | 30% |
|---|
"Higher than" is the share of the 100 with a lower figure. Financial figures from SEC filings, market figures from daily closes. Dividend yield and beta are under Valuation below.
Picked by YouTube search, not by us. Someone else's view, not advice.
Beat the forecast in 4 of the last 4 quarters.
The stock's move is from the close before the report to the close after it.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.
From Yahoo Finance, intuitive.com
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?Zacks, Oct 30
DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YZacks, Oct 30
What JPMorgan Active Growth ETF (JGRO) Bought: Tesla Leads on Oct. 28GuruFocus.com, Oct 30
RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsZacks, Oct 30ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?Zacks, Oct 29
Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook RaisedZacks, Oct 29
What Sent GE HealthCare Stock Higher?Trefis, Oct 29
What Have Medtronic Stock Holders Really Earned?Trefis, Oct 29
Is Intuitive Surgical Stock's Market Price Justified?Trefis, Oct 29BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock DownZacks, Oct 28Headlines are the outlets' views, not ours. Read the date before the headline. More on Yahoo Finance
Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?Zacks, Oct 30DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YZacks, Oct 30What JPMorgan Active Growth ETF (JGRO) Bought: Tesla Leads on Oct. 28GuruFocus.com, Oct 30RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin ClimbsZacks, Oct 30ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?Zacks, Oct 29Headlines are the outlets' views, not ours. Read the date before the headline. More on Yahoo Finance
Open-market buys and sells are the ones that say something; awards, exercises and tax withholding are routine.
Every transaction, in AdvancedSEC Form 4, public domain. The latest 40 of 92 Form 4 filings from the last 12 months are counted. A sale filled at several prices is one line at its average price. All Form 4s on EDGAR
Open-market buys and sells are the ones that say something; awards, exercises and tax withholding are routine.
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −61 | $441.60 | $26.9K | Form 4 ↗ |
| Oct 27, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −61 | $451.63 | $27.5K | Form 4 ↗ |
| Oct 26, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −61 | $451.75 | $27.6K | Form 4 ↗ |
| Oct 23, 2026 | Barratt Craig HDirector | Option exercise | +1,150 | $90.49 | $104K | Form 4 ↗ |
| Oct 23, 2026 | Barratt Craig HDirector | Sold on the market10b5-1 plan | −1,150 | $443.80 | $510K | Form 4 ↗ |
| Oct 23, 2026 | Widman FredrikVP Corporate Controller | Option exercise | +4,047 | $229.14average | $927K | Form 4 ↗ |
| Oct 23, 2026 | Widman FredrikVP Corporate Controller | Sold on the market10b5-1 plan | −4,047 | $453.21 | $1.8M | Form 4 ↗ |
| Oct 23, 2026 | Wadors Patricia LSVP Chief Human Resources Offi | Sold on the market10b5-1 plan | −1,078 | $443.80 | $478K | Form 4 ↗ |
| Oct 23, 2026 | Guthart Gary SDirector | Sold on the market10b5-1 plan | −20,095 | $451.61 | $9.1M | Form 4 ↗ |
| Oct 10, 2026 | Wadors Patricia LSVP Chief Human Resources Offi | Units vested | +2,140 | — | — | Form 4 ↗ |
| Oct 10, 2026 | Wadors Patricia LSVP Chief Human Resources Offi | Tax withholding | −1,062 | $423.96 | $450K | Form 4 ↗ |
| Oct 10, 2026 | Loeb GaryEVP & Chief Legal and Complian | Units vested | +2,612 | — | — | Form 4 ↗ |
| Oct 10, 2026 | Loeb GaryEVP & Chief Legal and Complian | Tax withholding | −1,296 | $423.96 | $549K | Form 4 ↗ |
| Sep 15, 2026 | Widman FredrikVP Corporate Controller | Option exercise | +1,089 | $94.52average | $103K | Form 4 ↗ |
| Sep 15, 2026 | Widman FredrikVP Corporate Controller | Sold on the market10b5-1 plan | −1,089 | $374.44 | $408K | Form 4 ↗ |
| Sep 11, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −25 | $365.79 | $9.1K | Form 4 ↗ |
| Sep 10, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −23 | $347.66 | $8.0K | Form 4 ↗ |
| Sep 9, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −23 | $350.20 | $8.1K | Form 4 ↗ |
| Sep 8, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −46 | $361.23 | $16.6K | Form 4 ↗ |
| Aug 21, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −77 | $375.57 | $28.9K | Form 4 ↗ |
| Aug 20, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −77 | $396.37 | $30.5K | Form 4 ↗ |
| Aug 19, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −77 | $394.26 | $30.4K | Form 4 ↗ |
| Aug 18, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −77 | $394.00 | $30.3K | Form 4 ↗ |
| Aug 17, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −77 | $390.67 | $30.1K | Form 4 ↗ |
| Aug 11, 2026 | Guthart Gary SDirector | Sold on the market10b5-1 plan | −10,000 | $400.00 | $4.0M | Form 4 ↗ |
| Aug 11, 2026 | Ladd Amy LDirector | Sold on the market10b5-1 plan | −72 | $393.10 | $28.3K | Form 4 ↗ |
| Aug 10, 2026 | Ladd Amy LDirector | Sold on the market10b5-1 plan | −400 | $379.00 | $152K | Form 4 ↗ |
| Aug 10, 2026 | Loeb GaryEVP & Chief Legal and Complian | Sold on the market10b5-1 plan | −400 | $379.00 | $152K | Form 4 ↗ |
| Jul 31, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −28 | $351.00 | $9.8K | Form 4 ↗ |
| Jul 30, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −28 | $346.83 | $9.7K | Form 4 ↗ |
| Jul 29, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −28 | $360.21 | $10.1K | Form 4 ↗ |
| Jul 28, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −28 | $365.58 | $10.2K | Form 4 ↗ |
| Jul 27, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −28 | $344.00 | $9.6K | Form 4 ↗ |
| Jul 10, 2026 | Rosa David J.CEO (CEO), Director | Units vested | +1,910 | — | — | Form 4 ↗ |
| Jul 10, 2026 | Rosa David J.CEO (CEO), Director | Tax withholding | −947 | $411.55 | $390K | Form 4 ↗ |
| Jun 12, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −25 | $414.13 | $10.4K | Form 4 ↗ |
| Jun 11, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −23 | $412.16 | $9.5K | Form 4 ↗ |
| Jun 10, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −23 | $424.14 | $9.8K | Form 4 ↗ |
| Jun 10, 2026 | Loeb GaryEVP & Chief Legal and Complian | Sold on the market10b5-1 plan | −400 | $424.14 | $170K | Form 4 ↗ |
| Jun 10, 2026 | Rosa David J.CEO (CEO), Director | Units vested | +1,358 | — | — | Form 4 ↗ |
| Jun 10, 2026 | Rosa David J.CEO (CEO), Director | Tax withholding | −674 | $426.61 | $288K | Form 4 ↗ |
| Jun 9, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −23 | $421.13 | $9.7K | Form 4 ↗ |
| Jun 8, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −23 | $420.12 | $9.7K | Form 4 ↗ |
| Jun 1, 2026 | Jeddi ImanSVP & GM da Vinci Platforms & | Option exercise | +5,625 | $77.00 | $433K | Form 4 ↗ |
| Jun 1, 2026 | Jeddi ImanSVP & GM da Vinci Platforms & | Sold on the market10b5-1 plan | −5,625 | $420.55 | $2.4M | Form 4 ↗ |
| May 22, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −18 | $439.80 | $7.9K | Form 4 ↗ |
| May 21, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −18 | $446.04 | $8.0K | Form 4 ↗ |
| May 20, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −18 | $440.38 | $7.9K | Form 4 ↗ |
| May 19, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −18 | $440.70 | $7.9K | Form 4 ↗ |
| May 18, 2026 | Brosius MarkEVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −18 | $422.47 | $7.6K | Form 4 ↗ |
| May 11, 2026 | Loeb GaryEVP & Chief Legal and Complian | Sold on the market10b5-1 plan | −400 | $446.95 | $179K | Form 4 ↗ |
| Apr 30, 2026 | Guthart Gary SDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Reed Monica PDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Reed Monica PDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Nachtsheim Jami KDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Nachtsheim Jami KDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Leonard Keith RDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Leonard Keith RDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Ladd Amy LDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Ladd Amy LDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Kolli SreelakshmiDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Kolli SreelakshmiDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Johnson Amal MDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Chew LewisDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Chew LewisDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Beery Joseph CDirector | Units vested | +531 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Beery Joseph CDirector | AwardRestricted Stock Units - 4-30-2026 | +554 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Barratt Craig HDirector | Units vested | +750 | — | — | Form 4 ↗ |
| Apr 30, 2026 | Barratt Craig HDirector | AwardRestricted Stock Units - 4-30-2026 | +643 | — | — | Form 4 ↗ |
| Apr 29, 2026 | Ladd Amy LDirector | Sold on the market10b5-1 plan | −119 | $463.50 | $55.2K | Form 4 ↗ |
| Apr 28, 2026 | Ladd Amy LDirector | Sold on the market10b5-1 plan | −500 | $473.46 | $237K | Form 4 ↗ |
| Mar 10, 2026 | Curet MyriamEVP & Chief Medical Officer | Option exercise | +105 | $229.39 | $24.1K | Form 4 ↗ |
| Mar 10, 2026 | Curet MyriamEVP & Chief Medical Officer | Sold on the market10b5-1 plan | −105 | $493.95 | $51.9K | Form 4 ↗ |
| Mar 9, 2026 | Brosius MarkSVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −645 | $485.01 | $313K | Form 4 ↗ |
| Mar 6, 2026 | Brosius MarkSVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −648 | $490.19 | $318K | Form 4 ↗ |
| Mar 5, 2026 | Brosius MarkSVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −648 | $495.20 | $321K | Form 4 ↗ |
| Mar 4, 2026 | Brosius MarkSVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −2,362 | $498.68 | $1.2M | Form 4 ↗ |
| Mar 3, 2026 | Brosius MarkSVP & Chief Mfg and Supply Cha | Sold on the market10b5-1 plan | −648 | $488.10 | $316K | Form 4 ↗ |
SEC Form 4, public domain. The latest 40 of 92 Form 4 filings from the last 12 months are counted. A sale filled at several prices is one line at its average price. All Form 4s on EDGAR